Mangoceuticals, Inc. (MGRX) Insider Trading
Insiders sold $174k and bought nothing on the open market.
None of the selling was scheduled in advance under a 10b5-1 plan. Director Alex P. Hamilton sold $153k on Nov 19, 2025, 97% of their stake, outside a plan. No executive or director has bought shares on the open market in the last two years.
Get an email when MGRX's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | Eugene M Johnston CFO | SoldNo plan | 3,333 | $1.17 | $4k | 2.7% | Form 4 |
| Dec 9, 2025 | Eugene M Johnston CFO | SoldNo plan | 5,000 | $1.20 | $6k | 3.9% | Form 4 |
| Dec 5, 2025 | Eugene M Johnston CFO | SoldNo plan | 10,000 | $1.13 | $11k | 7.2% | Form 4 |
| Nov 19, 2025 | Alex P. Hamilton Director | SoldNo plan | 125,000 | $1.22 | $153k | 97% | Form 4 |
- Dec 15, 2025No planEugene M JohnstonCFO · sold 3,333 at $1.17$4k2.7% of stake
- Dec 9, 2025No planEugene M JohnstonCFO · sold 5,000 at $1.20$6k3.9% of stake
- Dec 5, 2025No planEugene M JohnstonCFO · sold 10,000 at $1.13$11k7.2% of stake
- Nov 19, 2025No planAlex P. HamiltonDirector · sold 125,000 at $1.22$153k97% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Related stocks: Services-Misc Health & Allied Services, NEC
Spot a number that looks wrong? Check it in MGRX's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing MGRX
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.